Inhibitory Effect of Hexahydrocurcumin on Human Platelet Aggregation
Huei‐Ping Dong, Rei‐Cheng Yang, I‐Chun Chunag, Li‐Ju Huang, Hsing-Tan Li, Hsin‐Liang Chen, Chung‐Yi Chen
Abstract
Huei‐Ping Dong, Rei‐Cheng Yang, I‐Chun Chunag, Li‐Ju Huang, Hsing-Tan Li, Hsin‐Liang Chen, Chung‐Yi Chen
Abstract
The effects of hexahydrocurcumin on adenosine diphosphate (ADP)-induced human platelet aggregation were studied. Treatment of human platelet-rich plasma with hexahydrocurcumin resulted in an inhibitory effect on platelet aggregation, suggesting the potential of this compound as an anti-atherosclerogenic agent in humans.
OpenAlex reports 19 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The effects of hexahydrocurcumin on adenosine diphosphate (ADP)-induced human platelet aggregation were studied. Treatment of human platelet-rich plasma with hexahydrocurcumin resulted in an inhibitory effect on platelet aggregation, suggesting the potential of this compound as an anti-atherosclerogenic agent in humans.
Key concepts: Platelet, Adenosine diphosphate, Platelet aggregation, Inhibitory postsynaptic potential, Human plasma, Chemistry, Platelet-rich plasma, Adenosine